Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Breast Cancer Research and Treatment|November 24, 2017
Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training interventionChristina M Dieli-Conwright, Jean-Hugues Parmentier, Nathalie Sami, et al.
Research Square|November 19, 2025
Epigenetic Aging and Treatment Response to Semaglutide in the SLIM LIVER StudyMichael Corley, Alina Pang, Douglas Kitch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2007
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s)Pablo Tebas, Jiameng Zhang, Kevin Yarasheski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2025
The Bounce-Back Effect: What Happens After Cessation of Low-Dose Semaglutide in People with HIVKristine M Erlandson, Douglas W Kitch, Amy Kantor, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 10, 2010
Testosterone threshold levels and lean tissue mass targets needed to enhance skeletal muscle strength and function: the HORMA trialFred Sattler, Shalender Bhasin, Jiaxiu He, et al.
Environmental Health : a Global Access Science Source|March 20, 2022
Near-roadway air pollution, immune cells and adipokines among obese young adultsMd Mostafijur Rahman, Fei Fei Liu, Sandrah P Eckel, et al.
Npj Aging|April 21, 2026
Pilot study of epigenetic aging and treatment response to semaglutide in the SLIM LIVER studyMichael J Corley, Alina P S Pang, Douglas W Kitch, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2005
A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatmentThomas W Storer, Linda J Woodhouse, Fred Sattler, et al.
AIDS (London, England)|May 5, 2026
Semaglutide improves markers of cardiovascular risk in people with HIVJordan E Lake, Douglas W Kitch, Amy Kantor, et al.
Antiviral Research|October 23, 2004
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitisMichael J Borucki, John Spritzler, David M Asmuth, et al.
Pageof 3